You can buy or sell HTG Molecular and other stocks, options, ETFs, and crypto commission-free!
HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. Its customers include biopharmaceutical companies, academic research centers, and molecular testing laboratories. Read More The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.
52 Week High
52 Week Low
Seeking AlphaMar 12
HTG Molecular Diagnostics, Inc. (HTGM) CEO TJ Johnson on Q4 2018 Results - Earnings Call Transcript
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Q4 2018 Results Earnings Conference Call March 7, 2019 4:30 PM ET Company Participants Monique Kosse - Investor Relations TJ Johnson - Chief Executive Officer John Lubniewski - President, Chief Operating Officer Shaun McMeans - Chief Financial Officer Conference Call Participants Alex Nowak - Craig-Hallum David Delahunt - SVB Leerink Yi Chen - H.C. Wainwright Operator Greetings, and welcome to the HTG Molecular Diagnostics Fourth Quarter and Full Year...
Seeking AlphaMar 12
HTG Molecular Diagnostics (HTGM) Presents At Cowen And Company 39th Annual Health Care Conference - Slideshow
The following slide deck was published by HTG Molecular Diagnostics, Inc. in conjunction with this event. 1 26 Click to enlarge Notes:...
Associated PressMar 7
HTG Molecular Diagnostics Reports Full Year 2018 Results
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. TUCSON, Ariz., March 07, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the year en...
-$0.18 per share
-$0.07 per share